About Us
To redefine the boundary between beauty and biology, creating a future where skincare is synonymous with skin health, longevity, and intelligent self-care. To develop high-performance, science-backed formulations that deliver clinically proven results. We bridge the gap between dermatological research and daily beauty routines to provide safe, honest, and transformative solutions.
LongEVity Bioscience is part of Exosomics Group
LongEVity Bioscience is the last born in the Exosomics Group, established in 2024 because of the increasing demand of EV based products and services from the cosmetic and nutrition sectors.
Exosomics SpA is an R&D company with a main focus on human health. Its main focus is currently on EV based Liquid Biopsy solutions for imprved molecular diagnostics, patients' profiling and patients' monitoring in oncology. Exosomics sold its EV focused CDMO arm of business to LONZA in 2021.
HansaBioMed Life Sciences is the industrial arm of the Group, with an experienced team of scientists and a state of art infrastructure. HansaBioMed has been pioneering the EV field since 2007 and is currently a well established entity with a consolidated global market and a recognized reputation in the EV ecosystem. HansaBioMed offers products and services dedicated to the Life Sciences sector.
LongEVity Bioscience, a sprout with very deep roots
Despite being a newly established Company, LongEVity Bioscience has very deep roots and a remarcable expertise in the EV field due to belonging to the Exosomics family, having lead the field since early years on this century.
Thanks to the strong scientific background of the Group, the deep understanding of the EV field, twenty years experience in the sector, and an experienced management to run the Group, LongEVity is capable of offering high quality products and high quality services dedicated to the cosmetic and nutricion industries as only a few other global players can do.